The FDA's approval of TPOXX® (tecovirimat) -- the first and only approved antiviral treatment for smallpox -- marks a milestone for biosecurity and a triumph against one of the most deadly diseases in history. The approval also serves as an exemplary model of government working collaboratively with its interagency partners and industry to meet a national biodefense need. |
|
.png)
No hay comentarios:
Publicar un comentario